Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by thesheeton Sep 27, 2012 7:20pm
346 Views
Post# 20422759

rob mcewen

rob mcewen

i just saw his presentation at the toronto board of trade in february.

I recently spent time down at sick kids with my son for his cleft palate surgery and I am quite aware of that 20 ish story building that sick kids is building for RESEARCH.

There's a bleeping lot going on in that area of Toronto.

I starting looking for ways to invest in companies involved with Mcewens centre and happened upon 

SSS

I am starting my DD and like some of what the company has done re board and managment changes, but 2 cents is pretty low. The company could theoretically be dilisted at these levels, not that i m sugggesting that might be the case...

Does anyone know if Mcewen has endorsed this company in any way? i am curious because everything he touches is GOLD lol....  The simple fact that they are involved with the mcewen centre says something....

 

thesheet

Bullboard Posts